Sirona Announces Results of Shareholder Meeting
Vancouver, British Columbia – June 29, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (FRANKFURT: ZSB), (the “Company” is pleased to announce that all resolutions tabled at its Annual General and Special...
View ArticleSirona Retains Momentum Public Relations Inc. For Investor Relations
Vancouver, British Columbia – September 1, 2015 – Sirona Biochem Corp. (TSX-V: SBM, Frankfurt: ZSB), (the “Company”) is pleased to announce that it has retained Momentum Public Relations Inc....
View ArticleSirona Biochem Appoints German Private Bank Hauck & Aufhäuser as Designated...
Vancouver, British Columbia – September 11, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB), (the “Company”) is pleased to announce that the Company’s shares have been accepted for continuous...
View ArticleSirona Biochem Reaches Major Milestone by Successful Scale-Up of Skin...
Formulation testing by potential licensee gets underway shortly Vancouver, British Columbia – September 15, 2015 – Sirona Biochem Corp. (TSX-V: SBM, Frankfurt: ZSB, Xetra®: ZSB.DE) (the “Company”) is...
View ArticleSirona to Attend Cosmetic360 Conference in Paris
Vancouver, British Columbia – September 24, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB) (the “Company”) announces that it will attend Cosmetic360 in Paris, France, October 15-16,...
View ArticleSirona Announces Warrants Exercised
Vancouver, British Columbia – September 28, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB), (the “Company”) is pleased to announce that it has generated a total of $1,024,328 as a...
View ArticleSirona Biochem Presents New Results from Glycoprotein Program at BIO-Europe
Vancouver, British Columbia – October 26, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB) (the “Company”) announces that its Chief Business Development Officer, Attila Hajdu, will be...
View ArticleSirona Biochem Retains Strategic Advisor to Commercialize Glycoproteins
Vancouver, British Columbia – November 3, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB), (the “Company”) is pleased to announce that it has retained Dr. Mason Ross as a strategic...
View ArticleSirona Biochem Announces Positive Results with New Glycoproteins for...
Vancouver, British Columbia – November 10, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) is pleased to announce the protective effects of new glycoprotein compounds in human fibroblast studies...
View ArticleSirona Biochem Grants Stock Options
Vancouver, British Columbia – November 25, 2015 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) announces that it has granted incentive stock options under its Stock Option Plan to directors and...
View ArticleSirona Biochem Invited to Present at Dose of the Valley Conference, San...
Vancouver, British Columbia – January 25, 2016 – Sirona Biochem Corp. (TSX-V: SBM / FSE: ZSB), announces that it has been chosen for a second time, by the Consulate General of Canada, to present at the...
View ArticleSirona Biochem Selected to Present at BIO-Europe Spring
Vancouver, British Columbia – March 21, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB) (the “Company”) announces that its Chief Business Development Officer, Attila Hajdu, will be...
View ArticleSirona Biochem Begins Cell Preservation Research Collaboration with Dr....
Vancouver, British Columbia – April 11, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB)(Xetra: ZSB) (the “Company”) announces that it has entered into a research collaboration with Dr. Caigan...
View ArticleClik here to view.
Sirona Biochem Initiates Research and Development on New Therapies for Keloid...
Vancouver, British Columbia – April 18, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB) (the “Company”) announces that its CEO, Dr Howard Verrico, has approved two new therapeutic...
View ArticleSirona Biochem to Present New Test Results of SBM-TFC-1067 at Global Conferences
Vancouver, British Columbia – May 17, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (Xetra: ZSB) (the “Company”) is pleased to announce participation, in the form of presentations and...
View ArticleSirona Biochem Announces Wanbang Biopharmaceuticals to Proceed to Pre-IND...
Vancouver, British Columbia – June 13, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (Xetra: ZSB) (the “Company”) today announced that Wanbang Biopharmaceuticals has confirmed they will be...
View ArticleSirona Biochem Announces Positive Safety and Efficacy Data for Innovative...
Vancouver, British Columbia – June 16, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “Company”) announced positive preclinical safety and efficacy data with SBM-TFC-1067 in a...
View ArticleClik here to view.
Sirona Biochem CEO’s Report on Progress
Vancouver, British Columbia – June 30, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) today provided a business update. Dear Shareholders, I would like to provide an update on our...
View ArticleSirona Biochem CEO to Present at French Consulate and Business in France...
Vancouver, British Columbia – October 25, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “Company”) is pleased to announce that CEO, Dr. Howard Verrico, has been invited by the...
View ArticleSirona Biochem CEO’s Report on Progress
Vancouver, British Columbia – December 8, 2016 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) today provided a business update. Dear Shareholders, The following is an update on our...
View Article
